Evidence map›Paper›PMID 35065273›Full record

ArticleMolecular & cellular proteomics : MCP2022

Mass Spectrometric and Glycan Microarray-Based Characterization of the Filarial Nematode Brugia malayi Glycome Reveals Anionic and Zwitterionic Glycan Antigens.

Laudine M C Petralia, Angela van Diepen, Lena A Lokker, D Linh Nguyen, Erliyani Sartono, Vishal Khatri, Ramaswamy Kalyanasundaram, Christopher H Taron, Jeremy M Foster, Cornelis H Hokke

Open access · goldAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Serum antibody screening using glycan arrays.Chemical Society reviews · 2024
    Review
  5. High-mannose glycans fromFrontiers in immunology · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Laudine M C PetraliaDepartment of Parasitology, Leiden University - Center of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands; Division of Protein Expression & Modification, New England Biolabs, Ipswich, Massachusetts, USA.
Angela van DiepenDepartment of Parasitology, Leiden University - Center of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Lena A LokkerDepartment of Parasitology, Leiden University - Center of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
D Linh NguyenDepartment of Parasitology, Leiden University - Center of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Erliyani SartonoDepartment of Parasitology, Leiden University - Center of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Vishal KhatriDepartment of Biomedical Sciences, University of Illinois College of Medicine at Rockford, Rockford, Illinois, USA.
Ramaswamy KalyanasundaramDepartment of Biomedical Sciences, University of Illinois College of Medicine at Rockford, Rockford, Illinois, USA.
Christopher H TaronDivision of Protein Expression & Modification, New England Biolabs, Ipswich, Massachusetts, USA.
Jeremy M FosterDivision of Protein Expression & Modification, New England Biolabs, Ipswich, Massachusetts, USA.
Cornelis H HokkeDepartment of Parasitology, Leiden University - Center of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: C.H.Hokke@lumc.nl.
Leiden University Medical Center · NLNew England Biolabs (United States) · USIllinois College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Millions of people worldwide are infected with filarial nematodes, responsible for lymphatic filariasis (LF) and other diseases causing chronic disablement. Elimination programs have resulted in a substantial reduction of the rate of infection in certain areas creating a need for improved diagnostic tools to establish robust population surveillance and avoid LF resurgence. Glycans from parasitic helminths are emerging as potential antigens for use in diagnostic assays. However, despite its crucial role in host-parasite interactions, filarial glycosylation is still largely, structurally, and functionally uncharacterized. Therefore, we investigated the glycan repertoire of the filarial nematode Brugia malayi. Glycosphingolipid and N-linked glycans were extracted from several life-stages using enzymatic release and characterized using a combination of MALDI-TOF-MS and glycan sequencing techniques. Next, glycans were purified by HPLC and printed onto microarrays to assess the host anti-glycan antibody response. Comprehensive glycomic analysis of B. malayi revealed the presence of several putative antigenic motifs such as phosphorylcholine and terminal glucuronic acid. Glycan microarray screening showed a recognition of most B. malayi glycans by immunoglobulins from rhesus macaques at different time points after infection, which permitted the characterization of the dynamics of anti-glycan immunoglobulin G and M during the establishment of brugian filariasis. A significant level of IgG binding to the parasite glycans was also detected in infected human plasma, while IgG binding to glycans decreased after anthelmintic treatment. Altogether, our work identifies B. malayi glycan antigens and reveals antibody responses from the host that could be exploited as potential markers for LF.

Indexed as

Brugia malayiElephantiasis, FilarialAnimalsHumansImmunoglobulin GMacaca mulattaPolysaccharidesImmunoglobulin GPolysaccharidesantibodiesantigenic glycansantiglycan responseBrugia malayiglycan microarrayglycan sequencingGSL glycanlymphatic filariasisN-glycan

Identifiers

PMID35065273
PMCPMC9046957
OpenAlexW4205203903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.